Verapamil-d6
Verapamil-d6 ((±) -Verapamil-d6) is deuterium labeled Verapamil. Verapamil ((±) -Verapamil) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil also inhibits CYP3A4. Verapamil has the potential for high blood pressure, heart arrhythmias and angina research[1][2][3].
Product Specifications
Product Name Alternative
(±) -Verapamil-d6; CP-16533-1-d6
UNSPSC
12352005
Target
Isotope-Labeled Compounds
Related Pathways
Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease; Cancer; Cardiovascular Disease
Smiles
COC1=CC=C(C=C1OC)C(C(C([2H])([2H])[2H])C([2H])([2H])[2H])(CCCN(C)CCC2=CC=C(C(OC)=C2)OC)C#N
Molecular Formula
C27H32D6N2O4
Molecular Weight
460.64
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Staphylococcus haemolyticus Phosphopantetheine adenylyltransferase (coaD)
Recombinant Staphylococcus haemolyticus Phosphopantetheine adenylyltransferase (coaD)
Recombinant Staphylococcus haemolyticus Phosphopantetheine adenylyltransferase (coaD)
Recombinant Staphylococcus haemolyticus Phosphopantetheine adenylyltransferase (coaD)
Recombinant Staphylococcus haemolyticus Phosphopantetheine adenylyltransferase (coaD)
